Literature DB >> 1212664

The immunology of large bowel carcinoma in a rat model.

H O Sjögren, G Steele.   

Abstract

A rat large bowel carcinoma model has been established with close similarities to the immunological features of the corresponding human neoplasms as far as those are presently known: (1) common antigens with tissue-type specificity, (2) expression of immunogenic gut-specific embryonal antigens, (3) cell-mediated immunity present in tumor bearers, whose sera are capable of blocking the lymphocyte effect specifically, and (4) rapid disappearance of the serum blocking activity after tumor excision. It is suggested that this model is therefore particularly suitable for further detailed analysis of the potential function in vivo of tissue-type specific antigens. In addition, this model appears to be applicable to correlating alterations in immune status with tumor course after various modes of intervention such as chemotherapy and immunotherapy alone, or in combination with surgery.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1212664     DOI: 10.1002/1097-0142(197512)36:6<2469::aid-cncr2820360632>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Three new rat colon tumour cell lines from 1,2-dimethylhydrazine induced adenocarcinomas: morphology, karyotype and clonogenicity.

Authors:  M A Maley; A K House; D J Jenkyn; M V Agrez
Journal:  Br J Exp Pathol       Date:  1987-10

2.  Combination chemotherapy with 5-fluorouracil (5FU) and 1,3-bis(2-chloro-ethyl)-1-nitrosourea (BCNU) prolongs survival of rats with dimethylhydrazine-induced colon cancer.

Authors:  M Danzi; M R Lewin; J P Cruse; C G Clark
Journal:  Gut       Date:  1983-11       Impact factor: 23.059

3.  Adjuvant chemotherapy in a new metastasizing caecum tumor model.

Authors:  F A Zoetmulder; A Zwaveling
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

4.  Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats.

Authors:  J P Cruse; M R Lewin; C G Clark
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.